Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295744 · ClinicalTrials.gov registry record · NA
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
A NA study of Early Stage Breast Cancer, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06295744: Recruiting NA study of Early Stage Breast Cancer, sponsored by University of Wisconsin, Madison.
NCT06295744 is a NA study of Early Stage Breast Cancer that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants, below the 412-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06295744, a NA study of Early Stage Breast Cancer, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.
Primary Outcome
4-point scale where 1 is excellent, 2 is good, 3 is fair, and 4 is poor.
Conditions Studied
Interventions
- RADIATION Radiation Therapy
Study Locations (1)
Wisconsin
- UW Carbone Cancer Center - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-17 |
| Est. Completion | 2032-02 |
| Phase | NA |
What NCT06295744 shows while recruiting
NCT06295744 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 412-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Early Stage Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT06295744 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06295744 about?
NCT06295744 is a clinical study titled "Outcomes and Cosmesis With Whole Breast Irradiation and Boost". This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.
What is the current status of trial NCT06295744?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-17. Estimated completion is 2032-02.
What conditions does trial NCT06295744 study?
This clinical trial studies the following conditions: Early Stage Breast Cancer.
What interventions are being tested in trial NCT06295744?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT06295744?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295744 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Stage Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06295744's enrollment target sits among peer trials
50 17th of 21 higher than 5 of 21 other Early Stage Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Stage Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
RECRUITING · NA
-
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
RECRUITING · NA
-
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
RECRUITING · NA
-
Cardiometabolic Screening Program
RECRUITING · NA
-
SABER Study for Selected Early Stage Breast Cancer
RECRUITING · NA
-
POWER-remote Weight Loss Program in Early Stage Breast Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI